A Case of Fulminant Hepatitis due to Echovirus 9 in a Patient on Maintenance Rituximab Therapy for Follicular Lymphoma
Rituximab is a CD20 monoclonal antibody commonly used in the treatment of haematological malignancies. It causes lymphopenia with subsequent compromised humoral immunity resulting in an increased risk of infection. A number of infections and viral reactivations have been described as complicating Ri...
Saved in:
| Main Authors: | Ceri Morgan, S. J. Thomson, Joanne Legg, Santosh Narat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2015/454890 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
by: Wulyo Rajabto, et al.
Published: (2024-07-01) -
Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real‐world analysis from Taiwan Cancer Registry Database
by: Huai‐Hsuan Huang, et al.
Published: (2018-08-01) -
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study
by: Allison Barraclough, et al.
Published: (2025-03-01) -
Fulminant hepatitis B
by: Đokić Milomir, et al.
Published: (2003-01-01) -
Hepatic Regeneration in Fulminant Hepatic Failure
by: Gerald Y Minuk
Published: (1993-01-01)